Notably, Plasminogen Activator Inhibitor 1 (PAI-1) can be released by pancreatic tumor cells, as well as by activated platelets, to inhibit fibrinolysis or clot retraction [6]. Here, SERPINE1 is linked to pancreatic neoplasm.